Literature DB >> 4642792

Procaine in malignant hyperpyrexia.

R F Moulds, M A Denborough.   

Abstract

The caffeine contracture of normal human muscle, which has been used as a model for malignant hyperpyrexia, is greatly potentiated by halothane. Prior administration of procaine markedly reduces the halothane-potentiated caffeine contracture, and procaine given at the height of the contracture induces relaxation. Lignocaine, on the other hand, produces a variable response and sometimes increases the contracture.The muscle from a patient with an inherited susceptibility to malignant hyperpyrexia contracted spontaneously with halothane alone, and this contracture was reversed by procaine.These experiments support the therapeutic use of procaine in malignant hyperpyrexia.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4642792      PMCID: PMC1788768          DOI: 10.1136/bmj.4.5839.526

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  15 in total

Review 1.  Malignant hyperthermia: aetiology unknown.

Authors:  B A Britt; W Kalow
Journal:  Can Anaesth Soc J       Date:  1970-07

2.  Biochemical changes in malignant hyperpyrexia.

Authors:  M A Denborough; J F Forster; M C Hudson; N G Carter; P Zapf
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

3.  Myopathy and malignant hyperpyrexia.

Authors:  M A Denborough; P Ebeling; J O King; P Zapf
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

4.  Anaesthetic-induced malignant hyperpyrexia: a suggested method of treatment.

Authors:  G G Harrison
Journal:  Br Med J       Date:  1971-08

5.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

6.  Treatment of anaesthetic-induced malignant hyperpyrexia.

Authors:  G E Strobel
Journal:  Lancet       Date:  1971-01-02       Impact factor: 79.321

7.  Metabolic error of muscle metabolism after recovery from malignant hyperthermia.

Authors:  W Kalow; B A Britt; M E Terreau; C Haist
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

8.  An in-vitro model of anesthetic hypertonic hyperpyrexia, halothane--caffeine-induced muscle contractures: prevention of contracture by procainamide.

Authors:  G E Strobel; C P Bianchi
Journal:  Anesthesiology       Date:  1971-11       Impact factor: 7.892

9.  Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy.

Authors:  H Isaacs; M B Barlow
Journal:  Br Med J       Date:  1970-01-31

10.  The mechanism of the action of caffeine on sarcoplasmic reticulum.

Authors:  A Weber
Journal:  J Gen Physiol       Date:  1968-11       Impact factor: 4.086

View more
  12 in total

1.  Malignant hyperthermia and althesin.

Authors:  N Honda; K Konno; Y Itohda; M Nishino; S Matsushima; S Haseba; Y Honda; Y Gotoh
Journal:  Can Anaesth Soc J       Date:  1977-07

2.  Central-core disease and malignant hyperpyrexia.

Authors:  M A Denborough; X Dennett; R M Anderson
Journal:  Br Med J       Date:  1973-02-03

3.  Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.

Authors:  B A Britt
Journal:  Anesth Prog       Date:  1974 Jul-Aug

4.  Identification of susceptibility to malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-05-04

5.  Malignant hyperthermia: an investigation of five patients.

Authors:  B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal:  Can Anaesth Soc J       Date:  1973-07

6.  Central-core disease and malignant hyperpyrexia.

Authors:  D G Harriman; F R Ellis
Journal:  Br Med J       Date:  1973-03-03

7.  The caffeine test of isolated human muscle in relation to malignant hyperthermia.

Authors:  W Kalow; B A Britt; A Richter
Journal:  Can Anaesth Soc J       Date:  1977-11

8.  Biochemical basis of malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-05-04

9.  Ten cases of malignant hyperthermia in Norway.

Authors:  J Stovner; K R Innes; A Holen
Journal:  Can Anaesth Soc J       Date:  1976-09

10.  The use of procaine in acquired malignant hyperthermia in a patient with malignant melanoma metastatic to the parathyroid gland: a case report.

Authors:  H Borden; G J Hummer; C W Landon; J Paris
Journal:  Can Anaesth Soc J       Date:  1976-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.